title: Development and feasibility of a parental support intervention for adolescent smokers.
abstract: The aim of this investigation was to develop and evaluate the feasibility and acceptability of a parental support intervention. A new measure of perceived parental support for stopping smoking was also developed. The sample included 59 adolescent-parent pairs recruited from a mid-sized Midwestern town during 2000-2003. The mean +/- SD age of the participants (32 males, 27 females) was 16.3 +/- 0.9 (range 14-18) years and 86% were Caucasian, 7% American Indian, 5% African American, and 2% Hispanic. Participants were randomized to parental support or minimum behavioral intervention. Severity of nicotine dependence was evaluated using the Fagerström Tolerance Questionnaire, and perceived social support was evaluated using the Family Environment Scale and the new measure of perceived parent support for stopping smoking that was developed as part of this investigation. Treatment attendance, adherence, and acceptability were also evaluated. The parental support intervention was feasible but not superior to the minimum behavioral intervention with respect to attendance, retention, or change in support. This study expands on the knowledge of treating adolescent smokers and presents a new assessment measure. The study's limitations are noted. This investigation was funded by NICHHD.
authors: Division of Hematology & Oncology, Mayo Clinic, Jacksonville, Florida 32224, USA. ames.steven@mayo.edu
authors: Steven C
authors: SC
authors: Ames
authors: Emily
authors: E
authors: Rock
authors: Richard D
authors: RD
authors: Hurt
authors: Christi A
authors: CA
authors: Patten
authors: Ivana T
authors: IT
authors: Croghan
authors: Sarah M
authors: SM
authors: Stoner
authors: Paul A
authors: PA
authors: Decker
authors: Kenneth P
authors: KP
authors: Offord
authors: Melissa
authors: M
authors: Nelson
mesh_terms: D000293:Adolescent; D000294:Adolescent Behavior / Q000523:psychology*; D016642:Bupropion / Q000627:therapeutic use*; D018765:Dopamine Uptake Inhibitors / Q000627:therapeutic use*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D008297:Male; D016487:Parenting; D010290:Parents; D012720:Severity of Illness Index; D016540:Smoking Cessation / Q000706:statistics & numerical data*; D012944:Social Support; D011795:Surveys and Questionnaires; D014029:Tobacco Use Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*
chemical_list: D018765:Dopamine Uptake Inhibitors; D016642:Bupropion